ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

FGEN Company Profile and Key Details

NASDAQ : FGEN

FibroGen, Inc.

$0.30

-0.0037-1.23%

At Close 4:00 PM

55.69

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

FGEN Stock Price Chart

Stock Price Today

FibroGen, Inc. (FGEN) stock declined over -1.23%, trading at $0.30 on NASDAQ, down from the previous close of $0.30. The stock opened at $0.30, fluctuating between $0.29 and $0.31 in the recent session.

Stock Snapshot

0.2999

Prev. Close

0.3

Open

29.89M

Market Cap

100.92M

Number of Shares

0.2927

Day Low

0.3082

Day High

-0.19

P/E Ratio

93.1%

Free Float in %

-1.53

EPS (TTM)

-2.07

Book Value

-3.22

Cash Flow per Share

318.65K

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 15, 2025	0.30	0.31	0.29	0.30	319.06K
Apr 14, 2025	0.29	0.30	0.28	0.30	764.71K
Apr 11, 2025	0.26	0.28	0.26	0.28	438.91K
Apr 10, 2025	0.26	0.27	0.25	0.26	444.01K
Apr 09, 2025	0.24	0.28	0.23	0.26	1.21M
Apr 08, 2025	0.28	0.29	0.25	0.25	910.38K
Apr 07, 2025	0.27	0.28	0.25	0.27	1.22M
Apr 04, 2025	0.29	0.32	0.27	0.28	1.69M
Apr 03, 2025	0.30	0.30	0.28	0.29	1.06M
Apr 02, 2025	0.30	0.31	0.29	0.31	613.37K
Apr 01, 2025	0.30	0.33	0.30	0.30	887.07K
Mar 31, 2025	0.31	0.32	0.28	0.31	867.52K
Mar 28, 2025	0.34	0.34	0.30	0.31	2.28M
Mar 27, 2025	0.34	0.35	0.32	0.33	1.67M
Mar 26, 2025	0.34	0.36	0.33	0.34	1.15M
Mar 25, 2025	0.36	0.38	0.34	0.34	1.52M
Mar 24, 2025	0.33	0.38	0.33	0.37	2.75M
Mar 21, 2025	0.34	0.35	0.30	0.32	2.37M
Mar 20, 2025	0.35	0.36	0.33	0.34	1.42M
Mar 19, 2025	0.35	0.37	0.34	0.36	1.66M

Contact Details

San Francisco, CA 94158

United States

Website: https://www.fibrogen.comContact: 415 978 1200

About Company

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Frequently Asked Questions

What is the current FibroGen, Inc. (FGEN) stock price?

FibroGen, Inc. (NASDAQ: FGEN) stock price is $0.30 in the last trading session. During the trading session, FGEN stock reached the peak price of $0.31 while $0.29 was the lowest point it dropped to. The percentage change in FGEN stock occurred in the recent session was -1.23% while the dollar amount for the price change in FGEN stock was -$0.00.

FGEN's industry and sector of operation?

The NASDAQ listed FGEN is part of Biotechnology industry that operates in the broader Healthcare sector. FibroGen, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FGEN?

Ms. Christine L. Chung
Senior Vice President of China Operations
Mr. Enrique A. Conterno
Chief Executive Officer & Director
Dr. Elias Kouchakji
Senior Vice President of Clinical Devel., Drug Safety & Pharmacovigilance
Dr. Barry A. Berkowitz Ph.D.
Founder
Dr. John J. Hunter Ph.D.
Chief Scientific Officer
Dr. Mark Eisner M.D., M.P.H.
Executive Vice President & Chief Medical Officer
Mr. Michael D. Lowenstein J.D., Ph.D.
Chief Legal Officer
Mr. Thane Wettig
Interim Chief Executive Officer, Executive Vice President & Chief Commercial Officer
Mr. Juan Graham
Senior Vice President & Chief Financial Officer
Ms. Tricia Stewart
Chief People Officer

How FGEN did perform over past 52-week?

FGEN's closing price is 64.56% higher than its 52-week low of $0.18 where as its distance from 52-week high of $1.74 is -82.98%.

How many employees does FGEN have?

Number of FGEN employees currently stands at 225.

Link for FGEN official website?

Official Website of FGEN is: https://www.fibrogen.com

How do I contact FGEN?

FGEN could be contacted at phone 415 978 1200 and can also be accessed through its website. FGEN operates from 409 Illinois Street, San Francisco, CA 94158, United States.

How many shares of FGEN are traded daily?

FGEN stock volume for the day was 318.65K shares. The average number of FGEN shares traded daily for last 3 months was 3.41M.

What is the market cap of FGEN currently?

The market value of FGEN currently stands at $29.89M with its latest stock price at $0.30 and 100.92M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

FGEN Stock Price Chart

Stock Price Today

Stock Snapshot

0.2999

Prev. Close

0.3

Open

29.89M

Market Cap

100.92M

Number of Shares

0.2927

Day Low

0.3082

Day High

-0.19

P/E Ratio

93.1%

Free Float in %

-1.53

EPS (TTM)

-2.07

Book Value

-3.22

Cash Flow per Share

318.65K

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 15, 2025	0.30	0.31	0.29	0.30	319.06K
Apr 14, 2025	0.29	0.30	0.28	0.30	764.71K
Apr 11, 2025	0.26	0.28	0.26	0.28	438.91K
Apr 10, 2025	0.26	0.27	0.25	0.26	444.01K
Apr 09, 2025	0.24	0.28	0.23	0.26	1.21M
Apr 08, 2025	0.28	0.29	0.25	0.25	910.38K
Apr 07, 2025	0.27	0.28	0.25	0.27	1.22M
Apr 04, 2025	0.29	0.32	0.27	0.28	1.69M
Apr 03, 2025	0.30	0.30	0.28	0.29	1.06M
Apr 02, 2025	0.30	0.31	0.29	0.31	613.37K
Apr 01, 2025	0.30	0.33	0.30	0.30	887.07K
Mar 31, 2025	0.31	0.32	0.28	0.31	867.52K
Mar 28, 2025	0.34	0.34	0.30	0.31	2.28M
Mar 27, 2025	0.34	0.35	0.32	0.33	1.67M
Mar 26, 2025	0.34	0.36	0.33	0.34	1.15M
Mar 25, 2025	0.36	0.38	0.34	0.34	1.52M
Mar 24, 2025	0.33	0.38	0.33	0.37	2.75M
Mar 21, 2025	0.34	0.35	0.30	0.32	2.37M
Mar 20, 2025	0.35	0.36	0.33	0.34	1.42M
Mar 19, 2025	0.35	0.37	0.34	0.36	1.66M

Contact Details

San Francisco, CA 94158

United States

Website: https://www.fibrogen.comContact: 415 978 1200

About Company

Frequently Asked Questions

What is the current FibroGen, Inc. (FGEN) stock price?

FGEN's industry and sector of operation?

Who are the executives of FGEN?

How FGEN did perform over past 52-week?

FGEN's closing price is 64.56% higher than its 52-week low of $0.18 where as its distance from 52-week high of $1.74 is -82.98%.

How many employees does FGEN have?

Number of FGEN employees currently stands at 225.

Link for FGEN official website?

Official Website of FGEN is: https://www.fibrogen.com

How do I contact FGEN?

FGEN could be contacted at phone 415 978 1200 and can also be accessed through its website. FGEN operates from 409 Illinois Street, San Francisco, CA 94158, United States.

How many shares of FGEN are traded daily?

FGEN stock volume for the day was 318.65K shares. The average number of FGEN shares traded daily for last 3 months was 3.41M.

What is the market cap of FGEN currently?

The market value of FGEN currently stands at $29.89M with its latest stock price at $0.30 and 100.92M of its shares outstanding.

Employees	225
Beta	0.88
Sales or Revenue	$147.75M
5Y Sales Change%	-0.401%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	225
Beta	0.88
Sales or Revenue	$147.75M
5Y Sales Change%	-0.401%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

FGEN Company Profile and Key Details

FibroGen, Inc.

FGEN Stock Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

FGEN Stock Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions